4//SEC Filing
HEBARD GEORGE 4
Accession 0001140361-12-011943
CIK 0000727510other
Filed
Feb 28, 7:00 PM ET
Accepted
Feb 29, 5:35 PM ET
Size
8.3 KB
Accession
0001140361-12-011943
Insider Transaction Report
Form 4
HEBARD GEORGE
Director
Transactions
- Award
Common Stock
2012-02-27+13,737→ 13,737 total - Award
Stock Option (Right to Buy)
2012-02-27+10,297→ 10,297 totalExercise: $7.28Exp: 2022-02-27→ Common Stock (10,297 underlying)
Footnotes (4)
- [F1]Restricted Stock Units granted by the Issuer pursuant to the Issuer's 2011 Outside Director Compensation Plan and 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d). Each unit represents a contingent right to receive one share of the Issuer's Common Stock.
- [F2]The Restricted Stock Units will vest in three (3) tranches. Of the 13,737 Restricted Stock Units granted, 4,579 will vest on February 27, 2013, 4,579 will vest on February 27, 2014 and 4,579 will vest on February 27, 2015, in each case if the Reporting Person remains on the Board on such date. The Restricted Stock Units do not have an expiration date.
- [F3]Stock options granted by Issuer pursuant to the Issuer's 2011 Outside Director Compensation Plan and 2011 Stock Option and Incentive Plan and qualified under Rule 16b-3(d).
- [F4]The stock options will vest in three (3) tranches. Of the 10,297 stock options granted, 3,432 stock options will vest on February 27, 2013, 3,432 stock options will vest on February 27, 2014 and 3,433 stock options will vest on February 27, 2015, in each case if the Reporting Person remains on the Board on such date.
Documents
Issuer
ENZON PHARMACEUTICALS INC
CIK 0000727510
Entity typeother
Related Parties
1- filerCIK 0001531843
Filing Metadata
- Form type
- 4
- Filed
- Feb 28, 7:00 PM ET
- Accepted
- Feb 29, 5:35 PM ET
- Size
- 8.3 KB